TER Stock Cash Flow Statements

Teradyne Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Teradyne Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-29	2025-03-30	2024-12-31	2024-09-29	2024-06-30	2024-03-31	2023-12-31	2023-10-01	2023-07-02	2023-04-02	2022-12-31	2022-10-02	2022-07-03	2022-04-03	2021-12-31	2021-10-03	2021-07-04	2021-04-04	2020-12-31	2020-09-27	2020-06-28	2020-03-29	2019-12-31	2019-09-29	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-07-01	2018-04-01	2017-12-31	2017-10-01	2017-07-02	2017-04-02	2016-12-31	2016-10-02	2016-07-03	2016-04-03	2015-12-31	2015-10-04	2015-07-05	2015-04-05	2014-12-31	2014-09-28	2014-06-29	2014-03-30	2013-12-31	2013-09-29	2013-06-30	2013-03-31	2012-07-01	2012-04-01	2011-10-02	2010-07-04	2010-04-04	2009-10-04	2009-07-05	2009-04-05	2008-09-28	2008-06-29	2008-03-30	2007-12-31	2007-09-30	2007-07-01	2007-04-01	2006-12-31	2006-10-01	2006-07-02	2006-04-02	2005-10-02	2005-07-03	2005-04-03	2004-07-04	2004-04-04	2003-06-29	2003-03-30

cash flows from operating activities:
net income	78,373,000	98,896,000	146,253,000	145,649,000	186,273,000	64,197,000	117,054,000	128,117,000	120,050,000	83,531,000	172,301,000	183,485,000	197,787,000	161,928,000	224,040,000	256,718,000	328,319,000	205,512,000	196,332,000	222,717,000	188,907,000	176,191,000	125,073,000	135,860,000	97,397,000	109,138,000	143,788,000	119,981,000	101,036,000	86,974,000	-105,924,000	103,419,000	174,976,000	85,221,000	66,346,000	63,793,000	-223,546,000	49,986,000	-641,000	71,452,000	102,879,000	32,787,000	-103,811,000	82,949,000	101,205,000	929,000	22,343,000	69,459,000	66,556,000	6,589,000	111,387,000	33,564,000	54,745,000	122,149,000	50,100,000	6,675,000	-66,768,000	-90,668,000	-22,689,000	11,079,000	2,367,000	16,704,000	40,989,000	27,654,000	-7,636,000	10,874,000	60,565,000	82,405,000	44,913,000	-35,378,000	-45,464,000	-52,572,000	80,493,000	40,247,000	-52,489,000	-76,498,000
adjustments to reconcile net income from operations to net cash from operating activities:
depreciation	27,312,000	25,523,000	26,497,000	25,553,000	25,573,000	23,354,000	23,260,000	23,627,000	22,551,000	22,680,000	22,861,000	23,442,000	21,957,000	22,503,000	23,207,000	22,018,000	21,938,000	23,910,000	22,008,000	19,806,000	19,816,000	18,489,000	19,326,000	17,626,000	17,231,000	16,651,000	17,485,000	16,774,000	16,820,000	16,336,000	16,879,000	16,769,000	16,331,000	16,143,000	16,345,000	16,269,000	15,976,000	16,192,000	15,650,000	16,301,000	16,885,000	19,345,000	20,558,000	19,047,000	18,526,000	15,259,000	15,444,000	14,321,000	13,437,000	14,115,000	13,290,000	12,288,000	12,781,000	13,515,000	13,425,000	15,466,000	14,856,000	15,395,000	17,503,000	20,008,000	19,069,000	14,033,000	14,386,000	14,839,000	16,126,000	16,508,000	17,099,000	16,848,000	18,238,000	29,684,000	30,272,000	26,767,000	32,150,000	29,537,000	38,036,000	38,033,000
stock-based compensation	16,827,000	15,204,000	14,855,000	14,574,000	14,935,000	15,758,000	12,446,000	12,787,000	13,564,000	18,885,000	10,808,000	12,298,000	12,228,000	12,894,000	10,994,000	11,418,000	10,999,000	12,232,000	11,878,000	11,661,000	10,907,000	10,460,000	9,075,000	10,713,000	8,635,000	9,474,000	8,250,000	7,702,000	8,081,000	9,544,000	8,477,000	8,308,000	8,367,000	8,945,000	7,738,000	7,555,000	7,532,000	7,925,000	7,371,000	7,675,000	7,442,000	7,963,000	8,434,000	8,343,000	8,297,000	15,233,000	9,385,000	9,150,000	9,054,000	9,023,000	10,630,000	10,766,000	7,832,000	7,351,000	8,202,000	6,159,000	6,032,000	6,077,000	5,088,000	5,666,000	5,155,000	3,829,000	5,577,000	6,550,000	7,518,000	6,185,000	6,134,000	6,233,000	6,099,000
equity in net earnings of affiliate	5,927,000	5,584,000	6,136,000
losses (gains) on investments	-4,450,000	3,372,000	-83,000	-2,951,000	2,624,000	10,466,000					-1,451,000	2,463,000	6,972,000	2,001,000								4,657,000
benefit from excess and obsolete inventory	7,402,000	4,945,000	3,406,000	6,078,000	3,261,000	6,177,000	5,289,000	11,728,000	5,731,000	5,610,000	12,523,000	12,234,000	5,105,000	1,590,000	3,700,000	8,150,000	1,340,000	2,285,000	4,418,000	3,479,000	5,580,000	4,057,000	6,396,000	3,049,000	3,402,000	2,397,000	1,720,000	3,347,000	2,653,000	3,522,000	1,690,000	1,859,000	2,569,000	2,726,000	2,345,000	3,033,000	7,742,000	4,373,000	2,393,000	3,058,000	14,441,000	1,440,000	688,000	6,434,000	5,032,000	10,039,000	6,976,000	3,841,000	1,975,000	3,800,000	9,353,000	1,574,000	4,413,000	301,000	1,364,000	6,473,000	8,611,000	8,597,000									3,024,000
amortization	4,077,000	4,779,000	4,631,000	4,736,000	4,631,000	4,766,000	4,685,000	4,503,000	4,654,000	4,926,000	4,900,000	4,917,000	4,862,000	5,233,000	6,786,000	8,283,000	9,521,000	9,822,000	10,047,000	10,343,000	12,843,000	13,391,000	12,972,000	11,873,000	12,034,000	12,942,000	12,900,000	12,732,000	10,973,000	9,204,000	9,640,000	9,901,000	11,342,000	11,070,000	8,952,000	9,095,000	16,710,000	20,470,000	20,433,000	20,764,000	16,256,000	15,139,000	17,032,000	19,132,000	19,065,000	23,925,000	23,875,000	25,570,000	22,041,000	21,884,000	21,929,000	21,815,000	12,256,000	11,216,000	11,975,000	11,906,000	11,245,000	10,098,000	5,674,000	5,359,000	4,361,000	2,209,000	1,998,000	1,657,000	2,247,000	981,000	1,316,000	1,244,000	1,306,000	1,359,000	1,359,000	1,535,000	1,823,000	1,099,000	1,402,000	1,493,000
gain on sale of business			367,000	0
deferred taxes	-7,187,000	-7,811,000	-20,099,000	-9,431,000	-7,161,000	-9,669,000	-13,616,000	-10,455,000	-5,937,000	-7,634,000	-10,320,000	-4,776,000	-34,885,000	11,288,000	-6,573,000	-9,932,000	257,000	-1,057,000	-11,141,000	2,616,000	-5,338,000	-1,825,000	-6,479,000	-3,492,000	-691,000	1,206,000	3,898,000	7,130,000	8,616,000	8,696,000	37,784,000	2,884,000	-86,000	-3,477,000	-20,368,000	-21,110,000	-15,962,000	-5,496,000	6,849,000	-3,602,000	-8,540,000	-1,831,000	4,336,000	-3,050,000	-18,396,000	12,699,000	14,927,000	-3,981,000	-9,047,000	-6,183,000	8,238,000	7,699,000				-406,000
retirement plan actuarial losses				-2,262,000
other	-315,000	3,483,000	2,751,000	-6,281,000	453,000	787,000	-942,000	79,000	-200,000	108,000	1,613,000	218,000	345,000	177,000	28,000	44,000	-1,000	200,000	807,000	227,000	20,000	503,000	156,000	181,000	210,000	219,000	567,000	-652,000	-225,000	1,393,000	278,000	-724,000	1,151,000	2,000	-599,000	-425,000	92,000	484,000	-2,557,000	1,369,000	2,571,000	-1,417,000	1,395,000	945,000	1,306,000	-141,000	-490,000	-994,000	946,000	131,000	16,000	-454,000	-45,000	795,000	624,000	812,000	4,196,000	-3,241,000
changes in operating assets and liabilities, net of businesses acquired:
accounts receivable	36,443,000	13,053,000	12,607,000	-11,055,000	-46,156,000	-8,055,000	40,786,000	32,884,000	-39,897,000	37,204,000	46,380,000	150,632,000	-146,592,000	208,000	45,521,000	269,399,000	-285,186,000	-87,512,000	92,564,000	109,025,000	-204,261,000	-126,779,000	-3,651,000	12,689,000	-37,772,000	-41,706,000	59,869,000	101,596,000	-38,656,000	-140,747,000	-4,961,000	138,566,000	-90,397,000	-123,792,000	-27,335,000	183,890,000	-95,678,000	-42,552,000	33,850,000	51,376,000	-117,744,000	-24,749,000	171,730,000	-20,545,000	-84,243,000	-58,882,000	52,307,000	18,822,000	-61,594,000	-13,191,000	-124,577,000	-92,217,000	64,300,000	-69,278,000	-53,504,000	-65,779,000	-6,655,000	42,412,000	18,562,000	-10,552,000	15,040,000	42,179,000	-20,101,000	-45,270,000	-10,525,000	72,744,000	45,161,000	-17,809,000	-26,773,000	-34,040,000	-16,601,000	4,849,000	-40,301,000	-25,714,000	768,000	-49,911,000
inventories	7,342,000	-31,049,000	-2,420,000	-5,975,000	24,034,000	-6,932,000	-1,068,000	20,240,000	9,852,000	-23,697,000	-11,992,000	-22,135,000	-37,202,000	-9,480,000	-15,448,000	2,035,000	55,778,000	-35,870,000	-25,436,000	20,726,000	-19,546,000	15,818,000	-13,265,000	-11,696,000	470,000	-2,917,000	4,619,000	-12,834,000	-266,000	-21,017,000	21,190,000	31,919,000	54,003,000	-62,152,000	-14,338,000	18,379,000	30,924,000	-702,000	-17,817,000	9,876,000	17,540,000	5,960,000	12,905,000	19,798,000	15,834,000	2,635,000	-13,024,000	7,821,000	30,413,000	-4,040,000	-2,190,000	23,636,000	13,972,000	9,557,000	15,522,000	16,452,000	33,599,000	-4,140,000	-3,419,000	-1,301,000	78,000	17,918,000	2,397,000	4,262,000	20,602,000	11,707,000	18,242,000	15,085,000	33,433,000	1,513,000	19,517,000	13,484,000	-27,756,000	-26,024,000	16,271,000	24,430,000
prepayments and other assets	17,229,000	13,650,000	58,016,000	39,248,000	11,101,000	11,089,000	20,881,000	-34,398,000	-14,204,000	-15,380,000	-46,382,000	420,000	-20,446,000	-74,305,000	-37,282,000	-21,148,000	-31,285,000	-86,131,000	-23,667,000	8,728,000	-9,859,000	-39,620,000	-7,666,000	949,000	1,581,000	-18,648,000	-29,683,000	-30,360,000	2,320,000	-679,000	-5,108,000	2,937,000	3,321,000	1,104,000	-5,921,000	696,000	-12,509,000	-1,148,000	-12,495,000	1,475,000	10,908,000	3,146,000	-6,247,000	20,784,000	27,628,000	-628,000	-23,260,000	-9,035,000	-16,207,000	-1,070,000			-3,205,000
accounts payable and other liabilities	27,085,000	-9,950,000		-10,657,000	52,539,000	-105,548,000		28,513,000				-28,071,000				-21,726,000	97,361,000	-10,571,000		-32,021,000	148,901,000	-35,323,000	28,472,000	35,231,000	38,899,000	-53,323,000
deferred revenue and customer advances	2,856,000	10,200,000	8,552,000	885,000	4,183,000	-1,444,000	-7,693,000	-14,579,000	-2,233,000	-32,705,000	-337,000	-20,059,000	7,416,000	6,747,000	1,174,000	-6,490,000	7,237,000	7,952,000	3,385,000	7,934,000	29,568,000	-913,000	11,534,000	11,953,000	9,371,000	6,455,000	3,556,000	-695,000	874,000	9,644,000	-29,551,000	29,223,000	8,645,000	-3,333,000	-57,014,000	-52,692,000	119,908,000	-13,836,000	10,260,000	1,066,000	4,647,000	1,038,000	7,767,000	466,000	4,168,000	9,632,000	-19,115,000	-6,672,000	7,056,000	-10,146,000	-4,494,000	-1,704,000	-29,965,000
retirement plans contributions	-4,294,000	-1,282,000		-1,395,000	-1,353,000	-1,421,000		-1,216,000				-1,279,000				-1,384,000	-814,000	-1,925,000		-1,383,000	-1,239,000	-1,262,000		-1,361,000	-1,204,000	-1,210,000		-1,071,000	-1,153,000	-1,020,000				-947,000		-3,573,000	-1,048,000	-1,250,000		-999,000	-980,000	-1,019,000		-893,000	-963,000	-1,425,000		-1,058,000	-1,448,000	-1,063,000						-1,746,000			-1,573,000				-484,000
income taxes	-32,665,000	13,040,000	15,296,000	-21,520,000	-1,132,000	3,754,000	15,762,000	-29,069,000	-26,102,000	12,488,000	1,536,000	-42,185,000	18,426,000	-7,611,000	11,802,000	-14,778,000	-7,569,000	4,941,000	1,109,000	-13,782,000	22,564,000	15,278,000	17,640,000	-16,251,000	7,831,000	-22,804,000	-47,277,000	-6,844,000	-14,202,000	-12,106,000	157,994,000	1,445,000	75,000	14,288,000	14,207,000	4,221,000	58,000	-52,000																																					5,164,000	-2,468,000
net cash from operating activities	182,089,000	161,637,000	282,557,000	166,271,000	216,069,000	7,279,000	248,780,000	174,347,000	142,768,000	19,336,000	183,402,000	271,604,000	115,455,000	7,462,000	331,283,000	522,660,000	206,284,000	38,139,000	260,424,000	342,512,000	222,897,000	43,102,000	216,328,000	199,148,000	145,258,000	18,016,000	186,376,000	240,584,000	131,851,000	-81,930,000	147,473,000	309,830,000	230,313,000	-61,121,000	37,063,000	201,306,000	180,682,000	26,748,000	40,235,000	179,149,000	155,925,000	37,532,000	174,957,000	133,751,000	209,175,000	-25,821,000	43,846,000	154,452,000	105,471,000	-36,494,000	102,092,000	11,169,000	92,975,000	108,137,000	26,687,000	102,917,000	18,448,000	-65,205,000	38,748,000	46,525,000	34,421,000	87,924,000	29,140,000	41,480,000	-30,357,000	108,183,000	138,689,000			37,552,000	-25,508,000	-55,512,000	77,982,000	40,986,000	17,994,000	-44,358,000
capex	-50,408,000	-64,021,000	-57,385,000	-51,841,000	-44,846,000	-44,023,000	-44,336,000	-34,604,000	-39,258,000	-41,444,000	-34,577,000	-38,929,000	-45,744,000	-43,999,000	-29,310,000	-29,205,000	-34,707,000	-39,250,000	-38,105,000	-62,858,000	-47,314,000	-36,700,000	-38,594,000	-37,092,000	-33,245,000	-25,711,000	-26,110,000	-25,606,000	-27,866,000	-34,797,000	-32,128,000	-27,280,000	-23,901,000	-22,066,000	-19,020,000	-19,659,000	-26,259,000	-20,334,000	-23,151,000	-20,617,000	-24,961,000	-21,149,000	-22,630,000	-54,963,000	-60,192,000	-31,197,000	-23,806,000	-32,127,000	-28,251,000	-22,547,000	0	0	-22,156,000	-18,119,000	-17,587,000	0	0	0	0	0	0	0	0	0	0	0	0			0	0	0	-8,732,000	-16,046,000	-12,157,000	-1,596,000
free cash flows	131,681,000	97,616,000	225,172,000	114,430,000	171,223,000	-36,744,000	204,444,000	139,743,000	103,510,000	-22,108,000	148,825,000	232,675,000	69,711,000	-36,537,000	301,973,000	493,455,000	171,577,000	-1,111,000	222,319,000	279,654,000	175,583,000	6,402,000	177,734,000	162,056,000	112,013,000	-7,695,000	160,266,000	214,978,000	103,985,000	-116,727,000	115,345,000	282,550,000	206,412,000	-83,187,000	18,043,000	181,647,000	154,423,000	6,414,000	17,084,000	158,532,000	130,964,000	16,383,000	152,327,000	78,788,000	148,983,000	-57,018,000	20,040,000	122,325,000	77,220,000	-59,041,000	102,092,000	11,169,000	70,819,000	90,018,000	9,100,000	102,917,000	18,448,000	-65,205,000	38,748,000	46,525,000	34,421,000	87,924,000	29,140,000	41,480,000	-30,357,000	108,183,000	138,689,000			37,552,000	-25,508,000	-55,512,000	69,250,000	24,940,000	5,837,000	-45,954,000
cash flows from investing activities:
purchases of property, plant and equipment	-50,408,000	-64,021,000	-57,385,000	-51,841,000	-44,846,000	-44,023,000	-44,336,000	-34,604,000	-39,258,000	-41,444,000	-34,577,000	-38,929,000	-45,744,000	-43,999,000	-29,310,000	-29,205,000	-34,707,000	-39,250,000	-38,105,000	-62,858,000	-47,314,000	-36,700,000	-38,594,000	-37,092,000	-33,245,000	-25,711,000	-26,110,000	-25,606,000	-27,866,000	-34,797,000	-32,128,000	-27,280,000	-23,901,000	-22,066,000	-19,020,000	-19,659,000	-26,259,000	-20,334,000	-23,151,000	-20,617,000	-24,961,000	-21,149,000	-22,630,000	-54,963,000	-60,192,000	-31,197,000	-23,806,000	-32,127,000	-28,251,000	-22,547,000			-22,156,000	-18,119,000	-17,587,000
acquisition of businesses, net of cash acquired	-127,378,000	-17,002,000																		0	0	149,000				-6,970,000	0	1,158,000
purchase of investment in a business				-2,407,000
purchases of marketable securities	-6,397,000	-10,753,000	-10,699,000	-7,340,000	-11,715,000	-16,042,000	-24,120,000	-38,768,000	-29,742,000	-69,276,000	-20,234,000	-19,294,000	-81,904,000	-165,977,000	-152,311,000	-111,384,000	-186,482,000	-211,604,000	-411,768,000	-188,880,000	-112,429,000	-187,119,000	-57,162,000	-121,358,000	-108,997,000	-375,184,000	-109,223,000	-162,450,000	-156,747,000	-490,324,000														-320,750,000	-266,046,000	-257,260,000		-199,118,000	-333,556,000	-124,514,000
proceeds from the sale of a business, net of cash and cash equivalents sold			0	3,176,000
proceeds from maturities of marketable securities	5,222,000	27,381,000	5,190,000	6,305,000	12,420,000	14,438,000	13,595,000	49,450,000	14,529,000	7,468,000	40,849,000	42,440,000	42,970,000	96,682,000	88,871,000	111,064,000	265,985,000	194,228,000	170,271,000	126,423,000	84,527,000	98,457,000	218,455,000	160,279,000	91,992,000	141,201,000	336,339,000	464,238,000	257,164,000	212,698,000														118,129,000	97,114,000	280,322,000		133,355,000	148,994,000	119,552,000
proceeds from sales of marketable securities	2,854,000	5,633,000	435,000	2,311,000	555,000	20,734,000	24,438,000	1,386,000	27,648,000	7,929,000	8,858,000	115,558,000	113,061,000	30,581,000	57,029,000	93,325,000	54,819,000	61,293,000	2,395,000	5,950,000	11,656,000	15,005,000	45,312,000	17,820,000	37,014,000	5,440,000	2,958,000	14,111,000	28,382,000	800,671,000														83,242,000	51,455,000	101,363,000		282,342,000	28,561,000	21,694,000
proceeds from insurance				0	0	873,000
net cash from investing activities	-178,464,000	-61,773,000	-67,459,000	-49,796,000	-481,067,000	-24,020,000	-30,423,000	-27,536,000	-26,823,000	-94,863,000	-1,694,000	99,775,000	28,383,000	-82,713,000	-35,721,000	63,800,000	87,615,000	4,667,000	-277,207,000	-119,365,000	-63,014,000	-110,208,000	110,239,000	22,288,000	-28,236,000	-260,951,000	203,964,000	300,497,000	-44,343,000	462,892,000	-74,519,000	-428,357,000	113,681,000	126,394,000	-372,330,000	-252,101,000	-86,747,000	70,716,000	12,751,000	-77,101,000	12,671,000	-62,043,000	-78,481,000	-174,342,000	-177,669,000	97,619,000	-276,212,000	184,452,000	-184,252,000	-5,815,000	-61,091,000	-54,364,000	575,502,000	-81,701,000	-105,767,000	-29,486,000	-12,181,000	4,034,000	-39,481,000	-26,197,000	-248,917,000	115,211,000	174,044,000	-34,279,000	-138,323,000		405,318,000	-119,192,000	-82,741,000	-9,322,000	24,716,000	38,309,000	-78,506,000	-72,701,000	-23,558,000	-6,160,000
cash flows from financing activities:
repayments of borrowings on revolving credit facility				0
dividend payments	-19,178,000	-19,406,000	-19,487,000	-19,566,000	-19,000,000	-18,370,000	-16,797,000	-16,897,000	-17,019,000	-17,165,000	-17,133,000	-17,136,000	-17,547,000	-17,895,000	-16,266,000	-16,440,000	-16,604,000	-16,667,000	-16,612,000	-16,604,000	-16,580,000	-16,686,000	-15,036,000	-15,250,000	-15,392,000	-15,627,000	-16,002,000	-16,638,000	-17,094,000	-17,588,000	-13,717,000	-13,805,000	-13,904,000	-14,021,000	-12,071,000	-12,123,000	-12,172,000	-12,253,000	-12,279,000	-12,577,000	-12,808,000	-13,049,000
repurchase of common stock	-117,398,000	-157,475,000	-143,521,000	-24,747,000	-8,189,000	-22,117,000	-50,749,000	-118,647,000	-134,537,000	-93,308,000	-2,082,000	-217,201,000	-331,334,000	-201,465,000	-193,820,000	-209,596,000	-151,396,000	-45,188,000	0	0	-9,426,000	-79,039,000	-131,218,000	-121,560,000	-90,754,000	-156,468,000	-261,215,000	-201,468,000	-226,519,000	-134,276,000	-48,483,000	-57,493,000	-56,598,000	-37,730,000	-61,239,000	-28,309,000	-28,782,000	-28,001,000	-73,106,000	-98,527,000	-81,666,000	-46,650,000																	0	-58,214,000	-32,977,000	-70,103,000	-175,952,000	-24,041,000	-3,569,000	-28,251,000
payments related to net settlement of employee stock compensation awards	-228,000	-14,726,000	-267,000	-399,000	-319,000	-13,115,000	-202,000	-278,000	-438,000	-19,870,000	-183,000	-207,000	-1,732,000	-31,048,000	-258,000	-251,000	-1,119,000	-30,675,000	-279,000	-216,000	-449,000	-22,070,000	-191,000	-104,000	-128,000	-14,318,000	-182,000	-90,000	-122,000	-19,629,000	-297,000	-146,000	-149,000	-12,289,000
proceeds from borrowings on revolving credit facility			0	0
issuance of common stock under stock purchase and stock option plans	0	14,792,000	65,000	15,429,000	4,902,000	16,934,000	175,000	17,485,000	602,000	15,997,000	0	12,197,000	61,000	16,475,000	96,000	9,000	15,437,000	17,144,000	1,999,000	13,771,000	5,000	12,752,000	32,000	14,191,000	821,000	14,268,000	14,000	10,278,000	27,000	10,654,000	31,000	9,247,000	131,000	15,084,000
net cash from financing activities	-136,804,000	-176,815,000	-163,210,000	-29,283,000	-22,606,000	-36,668,000	-91,102,000	-127,614,000	-153,695,000	-129,501,000	-34,152,000	-232,060,000	-372,150,000	-254,627,000	-251,241,000	-461,447,000	-169,235,000	-126,661,000	-14,892,000	-3,049,000	-26,450,000	-113,895,000	-146,413,000	-122,723,000	-105,453,000	-199,760,000	-277,385,000	-207,918,000	-243,708,000	-174,410,000	-62,466,000	-62,197,000	-70,520,000	-50,006,000	347,695,000	-34,844,000	-32,198,000	-42,811,000	-82,498,000	-108,516,000	-86,856,000	-50,800,000	-13,924,000	-2,330,000	-9,507,000	-180,810,000			1,163,000	8,608,000	14,659,000	2,855,000	-28,712,000	35,794,000	4,956,000	-85,000	47,163,000	17,523,000	7,212,000	-57,314,000	-24,795,000	-69,842,000	-167,321,000	-19,575,000	6,244,000	-287,985,000	-125,496,000			3,055,000
effects of exchange rate changes on cash and cash equivalents	-3,201,000	-771,000	-8,570,000	940,000	2,105,000	3,241,000	-6,645,000	4,556,000	1,750,000	-537,000	-3,529,000	-596,000	5,732,000	2,282,000	-1,576,000	0	-1,372,000	883,000	616,000	-349,000	-1,496,000	571,000	-169,000	119,000	-190,000	-329,000	-222,000	472,000	-1,289,000	1,478,000	678,000	1,052,000	129,000	1,595,000
decrease in cash and cash equivalents	-136,380,000	-77,722,000		88,132,000	-285,499,000	-50,168,000		23,753,000	-36,000,000	-205,565,000				-327,596,000				-82,972,000			131,937,000	-180,430,000																				-75,311,000			21,999,000	-109,012,000				-33,701,000					-74,725,000			-43,648,000	6,479,000	-36,986,000	-239,291,000			-12,374,000	-162,436,000			13,741,000	-17,918,000		9,048,000	-19,135,000	1,365,000	-5,474,000	18,023,000	-31,640,000
cash and cash equivalents at beginning of period	0	553,354,000		0	0	757,571,000		0	0	854,773,000		0	0	1,122,199,000		0	0	914,121,000		0	0	773,924,000		0	0	926,752,000		0	0	429,843,000		0	0	307,884,000		0	0	264,705,000		0	0	294,256,000		0	0	341,638,000		0	0	338,920,000	0	573,736,000	0	0	416,737,000	0	0	322,705,000	0	0	562,371,000		0	0	568,025,000		0	0	340,699,000	0	0	209,147,000	0	228,444,000	0	251,521,000
cash and cash equivalents at end of period	-136,380,000	475,632,000		88,132,000	-285,499,000	707,403,000		23,753,000	-36,000,000	649,208,000		138,723,000	-222,580,000	794,603,000		125,013,000	123,292,000	831,149,000		219,749,000	131,937,000	593,494,000		98,832,000	11,379,000	483,728,000		333,635,000	-157,489,000	637,873,000		-179,672,000	273,603,000	324,746,000		-83,158,000	61,737,000	319,358,000		-6,468,000	81,740,000	218,945,000		-42,921,000	21,999,000	232,626,000		345,267,000	-77,618,000	305,219,000	55,660,000	533,396,000	639,765,000	61,984,000	342,012,000	72,660,000	55,024,000	279,057,000	6,479,000	-36,986,000	323,080,000		35,863,000	-12,374,000	405,589,000		418,511,000	13,741,000	322,781,000	31,285,000	9,048,000	190,012,000	1,365,000	222,970,000	18,023,000	219,881,000
non-cash investing activities:
capital expenditures incurred but not yet paid:	-2,413,000	7,135,000	214,000	555,000	38,000	3,086,000	343,000	651,000	-2,082,000	3,823,000	-523,000	494,000	-645,000	2,500,000	-313,000	-2,217,000	663,000	3,840,000
investments in businesses		-3,011,000
proceeds from life insurance								0	0	460,000										0				2,639,000	0	273,000														0	0	1,098,000		0	0	4,391,000										0	0	1,076,000
retirement plans actuarial (gains) losses																																															-8,981,000	0
gain on sale of asset
accounts payable and other accrued expenses										-83,208,000				-124,382,000													-2,431,000	24,279,000	38,551,000	-46,706,000	38,276,000	-29,206,000	42,057,000	-7,553,000	46,235,000	-32,749,000	-7,566,000	-7,626,000	-4,450,000	-729,000	73,542,000	-20,150,000	-74,539,000	-23,687,000	98,283,000	-45,487,000	14,607,000	15,645,000	32,109,000	-47,258,000	36,775,000	-9,635,000
retirement plan contributions										-1,234,000				-1,329,000																																						-1,061,000	-1,152,000	-18,018,000	-6,659,000			-1,604,000			-1,104,000				-1,158,000
issuance of convertible loan							0
proceeds from sale of asset
payments of borrowings on revolving credit facility
payments of convertible debt principal							-23,529,000	-9,277,000	-2,303,000	-15,155,000	-14,754,000	-9,713,000	-21,598,000	-20,694,000	-40,993,000	-235,169,000	-15,553,000	-51,275,000
increase in cash and cash equivalents											144,027,000	138,723,000			42,745,000	125,013,000			-31,059,000				179,985,000	98,832,000	11,379,000	-443,024,000	112,733,000	333,635,000	-157,489,000	208,030,000	11,166,000	-179,672,000	273,603,000	16,862,000	9,947,000	-83,158,000	61,737,000	54,653,000					82,552,000				-231,230,000	345,267,000			55,660,000	-40,340,000	639,765,000			72,660,000										-187,008,000
cash and cash equivalents at beginning of year
cash and cash equivalents at end of year
supplementary disclosure of cash flow information:
cash paid for:
interest																																																																											8,478,000	2,183,000
changes in operating assets and liabilities
retirement plans actuarial losses																							7,728,000
(gains) losses on investments							-11,756,000	1,586,000	-2,507,000	-2,238,000								-2,491,000								-2,828,000
gains on sale of asset
loss on convertible debt conversion															3,431,000	20,153,000	1,175,000	4,069,000
contingent consideration fair value adjustment																							-2,797,000	-7,759,000	-11,671,000	2,970,000					5,973,000	-286,000
purchase of investment and acquisition of business															0	0
payments of contingent consideration																			0	0	0	-8,852,000	0	0	0	-27,615,000	0	0	0	-13,571,000	0	0	0	-1,050,000	0			-11,697,000									0	0	-75,000	-313,000	0	-5,824,000
contingent consideration fair value adjustments
loss on convertible debt conversions
retirement plans actuarial gains																																				662,000	-669,000	-1,193,000
purchase of investment
gains on investments															-1,660,000	-100,000				-3,046,000
investment impairment
contingent consideration adjustment																0	0	-7,227,000		-27,206,000	29,259,000	-10,020,000						-768,000	-3,500,000	-4,968,000				634,000	5,445,000	7,973,000	1,305,000	1,173,000	5,089,000	-1,000,000											-6,548,000	-1,858,000
retirement plan actuarial (gains) losses
changes in operating assets and liabilities, net of business acquired:
proceeds from government subsidy for property, plant and equipment																											0
purchase of investment and acquisition of businesses, net of cash acquired																							-57,772,000
supplementary disclosure of cash flows information:
supplemental cash flow disclosure
capital expenditures incurred but not yet paid																				-3,162,000
property insurance recovery																																			0	-312,000
adjustments to reconcile net income to net cash from operating activities:
gains on marketable securities
(gains) losses on marketable securities
purchase of investments and acquisition of businesses, net of cash acquired
goodwill impairment																																			0	0
acquired intangible assets impairment
tax benefit related to employee stock compensation awards																																			-2,799,000				-1,502,000	-2,321,000
proceeds from issuance of convertible notes, net of issuance costs
purchase of convertible note hedges
proceeds from issuance of warrants
proceeds from property insurance																															0				0	0
retirement plan actuarial gains
acquisition of business, net of cash acquired																														-25,356,000										-409,000																0			0	-4,861,000	-280,463,000
gain from the sale of an equity investment																																							0	0	-624,000	-4,782,000
non-cash charge for the sale of inventories revalued at the date of acquisition																																							0																	5,700,000	3,925,000	1,238,000	0	0	4,346,000
purchases of available-for-sale marketable securities																															-355,394,000	-701,704,000	-181,502,000	-153,317,000	-780,430,000	-438,526,000	-215,533,000	-221,778,000	-466,396,000	-367,356,000	-254,615,000	-335,635,000									-76,676,000	-80,095,000	-94,720,000	-128,421,000	-95,399,000				-94,894,000			-55,220,000	-89,813,000	-117,853,000	-125,499,000	-24,352,000	-14,973,000	-241,306,000	-116,291,000	-18,919,000	-101,766,000	-15,487,000	-70,589,000	-65,318,000	-47,845,000	-58,774,000
proceeds from maturities of available-for-sale marketable securities																															228,426,000	165,648,000	219,423,000	88,184,000	41,070,000	74,138,000	54,566,000	73,458,000	29,901,000	98,947,000	91,194,000	140,222,000
proceeds from sales of available-for-sale marketable securities																															84,577,000	129,915,000	99,661,000	213,593,000	386,050,000	131,946,000	95,428,000	239,370,000	472,397,000	212,334,000	482,761,000	148,639,000												40,198,000	7,069,000
proceeds from the sale of an equity investment																																							0	0	624,000	4,782,000
payment of revolving credit facility costs																																							0	0
gain on insurance recovery
changes in operating assets and liabilities:
impairment of fixed assets																																			0	0
issuance of common stock under stock option and stock purchase plans
payments of long-term debt																																											3,000	0	0	-190,975,000	-1,471,000	0			0	-1,246,000	-1,296,000	0	-1,123,000
intangible assets impairment																																				0
non-cash charge for the sale of inventories revalued at date of acquisition
issuance of common stock under employee stock purchase and stock option plans																																					8,756,000	9,140,000		267,000	8,979,000	8,899,000				10,165,000
payment of contingent consideration
proceeds from (purchases of) life insurance
accrued income taxes																																								2,416,000	18,599,000	4,662,000	-1,308,000	4,713,000	15,104,000	-9,609,000	-12,102,000	10,786,000	12,049,000	-9,085,000			-8,470,000								-7,573,000				-33,417,000	7,713,000	10,257,000	8,883,000	5,965,000	4,649,000	-3,214,000	-5,282,000	5,866,000	-63,000		-1,425,000
non cash charge for the sale of inventories revalued at the date of acquisition																																																			1,218,000	4,871,000
adjustments to reconcile income from operations to net cash from operating activities:
tax benefit related to stock options and restricted stock units																																											1,191,000	-55,000			-1,789,000	777,000
cash paid during the year for:
impairment loss on property, plant and equipment																																																0
issuance of common stock under employee stock purchase and stock options plans																																												10,387,000
payments of dividend																																												-12,772,000
less: income from discontinued operations																																																					0
less: gain on disposal of discontinued operations																																																					0
income from continuing operations																																																			111,387,000	33,564,000	54,745,000						-23,457,000	11,079,000	2,367,000	17,153,000	35,198,000			10,874,000	64,451,000	82,405,000	44,913,000
adjustments to reconcile income from continuing operations to net cash from operating activities:
changes in operating assets and liabilities, net of businesses sold and acquired:
net cash from continuing operations																																																			102,092,000	11,169,000							37,980,000	46,525,000	34,421,000	88,373,000	29,245,000			108,183,000	142,575,000	131,327,000	71,887,000
net cash from discontinued operations																																																														-449,000	-105,000			0
(purchases of ) proceeds from life insurance
issuance of common stock under employee stock option and stock purchase plans																																																7,140,000	717,000	8,921,000	7,059,000	9,925,000	164,000	35,794,000	6,079,000	984,000	6,819,000	7,453,000	7,212,000	900,000	8,182,000		8,631,000	4,466,000	9,813,000		7,816,000	1,606,000	12,584,000	3,055,000	9,917,000	20,053,000	2,043,000	26,316,000	23,886,000	19,169,000
net cash from (used) for financing activities
other assets																																																			3,142,000	1,885,000		-4,703,000	20,064,000	-7,077,000	10,013,000	-7,621,000	-12,301,000	3,259,000	-9,454,000	-7,320,000	-14,203,000	-1,696,000	-1,739,000	2,255,000	12,390,000	-483,000	-7,606,000	3,794,000	-3,034,000	-5,099,000	-1,777,000	5,425,000	-14,108,000	-3,532,000
proceeds from sales of trading marketable securities																																																						23,550,000	150,000
income taxes payments
changes in operating assets and liabilities, net of businesses sold:
proceed from sales of available-for-sale marketable securities
investments in property, plant and equipment																																																				-27,074,000				-9,155,000	-11,341,000	-6,087,000	-18,826,000	-27,718,000	-28,984,000	-22,300,000	-19,177,000	-22,676,000	-21,935,000	-27,747,000	-30,068,000	-27,181,000	-25,421,000	49,558,000	-37,778,000	-42,526,000
proceeds from sales and maturities of available-for-sale marketable securities																																																				52,805,000	692,378,000					9,045,000
accounts payable and accrued expenses																																																					-38,204,000
net cash from operating activities from continuing operations																																																					92,975,000
net cash from operating activities from discontinued operations																																																					0
net cash from investing activities from continuing operations																																																					575,502,000
net cash from investing activities from discontinued operations																																																					0
loss on sale and impairment of marketable securities																																																						87,000	323,000	-603,000	-31,000	2,563,000
non-cash charge for sale of inventories revalued at the date of acquisition
revolving credit facility issue costs																																																								0
accounts payable, deferred revenue and accrued expenses																																																						23,819,000	-34,749,000	108,885,000	5,157,000	-44,311,000	-15,204,000	10,123,000	287,000		12,916,000	30,036,000	-40,052,000		-15,363,000	32,574,000	-11,788,000	25,373,000	-15,130,000	-41,703,000	26,396,000	11,121,000
proceeds from long-term debt																																																										10,070,000
repayment of revolving credit facility principal																																																								0
effect of exchange rate changes on cash and cash equivalents																																																						-246,000	-601,000	-686,000
income from discontinued operations																																																															-105,000
in-process research and development charge																																																											0	0	1,100,000		0	0	16,700,000
loss on sale of land and building
income taxes payable																																																											-2,128,000				-4,837,000
proceeds from sale of an equity investment
proceeds from sale and maturities of available-for-sale marketable securities																																																								11,139,000			42,023,000	29,247,000	60,530,000		264,192,000	105,533,000	26,711,000		407,351,000	112,906,000	58,742,000	32,306,000	150,133,000	95,908,000
proceeds from sale of land and building																																																											26,356,000							5,397,000	42,988,000			3,720,000
net proceeds from long-term debt																																																								0
repayment of long-term debt principal
gain on sale of land and building																																																											22,565,000							-779,000	-16,583,000			47,000
gain on sale from discontinued operations
gain on sale of product lines																																																														0	0			0	-20,000	-157,000	-229,000
gain on life insurance
gain on sale of an equity investment
impairment of marketable securities
other non-cash items																																																											614,000	308,000	-599,000	-957,000	-422,000	692,000	516,000	520,000	426,000	2,834,000	-23,000	-563,000	1,431,000	-764,000	-345,000	722,000	2,174,000	2,682,000
changes in operating assets and liabilities, net of businesses and product lines acquired and sold:
acquisition of technology																																																														0	0	0	-17,600,000
proceeds from sale of product lines and business																																																																			20,000			0
benefit from inventory																																																												1,906,000	1,348,000		417,000	64,000	461,000				8,302,000		2,165,000	2,678,000	2,304,000	4,259,000
benefit from doubtful accounts																																																															0												0	842,000
adjustments to reconcile income from continuing operations to net cash provided (used for) by operating activities:
impairment of long-lived assets																																																																		0	0	0	50,000	0	9,157,000	595,000	-100,000	377,000	6,494,000	7,494,000
in-process research and development
gain on sale of land and buildings
benefit from inventory obsolescence
deferred income tax credit
tax credit related to pension funding
changes in operating assets and liabilities, net of businesses and product lines sold and acquired:
accounts payable, deferred revenue and accruals																																																																											18,296,000	6,198,000
proceeds from sale of land and buildings
proceeds from sale of product lines																																																														0							229,000			414,000				2,114,000
payments of long-term debt and notes payable
income taxes paid
changes in operating assets and liabilities, net of product lines and businesses sold:
payments of long term debt and notes payable																																																																			-24,000,000	0	-19,648,000	0	-77,000	-21,985,000
(decrease)/increase in cash and cash equivalents
fire loss on spare parts
net cash from (used by) investing activities
changes in operating assets and liabilities, net of product lines sold:
adjustments to reconcile net income from continuing operations to net cash from operating activities:
net cash provided (used for) by operating activities																																																																					71,887,000
net cash used by financing activities																																																																					-7,064,000
gain on sale of product lines and business																																																																						0
benefit from excess or obsolete inventory
increase in test equipment manufactured by teradyne
net cash flows from financing activities																																																																								-1,932,000	1,889,000	26,241,000	23,587,000	18,878,000
(gain) loss on sale of product lines
additions to property, plant and equipment																																																																									-8,732,000	-16,046,000	-12,157,000	-1,596,000
increase in equipment manufactured by teradyne																																																																									-30,264,000	-23,424,000	-6,417,000	-16,901,000
proceeds from asset disposal																																																																												5,964,000
maturities of available-for-sale marketable securities																																																																									30,214,000	32,087,000	42,861,000	33,128,000
maturities of held-to-maturity marketable securities																																																																											0	29,905,000
loss on sale of product lines																																																																											2,212,000	5,836,000
payments of long term debt																																																																										-75,000		-291,000
deferred income tax benefit
proceeds from asset disposals
proceeds from the sale of product lines
purchases of held-to-maturity marketable securities
(payments of) proceeds from long term debt
cash paid (received) during the period for:

We provide you with 20 years of cash flow statements for Teradyne stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Teradyne stock. Explore the full financial landscape of Teradyne stock with our expertly curated income statements.

The information provided in this report about Teradyne stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.